The polymeric antigen BLSOmp31 confers protection against Brucella ovis infection in rams

Vaccine

Volumn 27, Issue 48, 2009, Pages 6704-6711

  Estein, Silvia M ^a   Fiorentino, María A ^b   Paolicchi, Fernando A ^b   Clausse, María ^a   Manazza, Jorge ^b   Cassataro, Juliana ^c,d   Giambartolomei, Guillermo H ^c,d   Coria, Lorena M ^c   Zylberman, Vanesa ^e   Fossati, Carlos A ^d   Kjeken, Rune ^f   Goldbaum, Fernando A ^e  

^a UNIVERSIDAD NACIONAL DEL CENTRO DE LA PROVINCIA DE BUENOS AIRES   (Argentina)

^b INSTITUTO NACIONAL DE TECNOLOGÍA AGROPECUARIA INTA   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^e Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^f Inovio Biomedical Corporation   (United States)

Author keywords

BLSOmp31; Brucella ovis; Immunogenicity; Protection; Rams

Indexed keywords

ADJUVANT; DNA VACCINE; FREUND ADJUVANT; GAMMA INTERFERON; IMMUNOGLOBULIN G ANTIBODY; PROTEIN; RECOMBINANT PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIOLYSIS; BRUCELLOSIS; CHIMERA; CONTROLLED STUDY; ELECTROPORATION; HUMORAL IMMUNITY; IMMUNITY; IMMUNIZATION; NONHUMAN; PLASMID; PRIORITY JOURNAL; RAM (SHEEP);

ADJUVANTS, IMMUNOLOGIC; AGGLUTINATION TESTS; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; BRUCELLA OVIS; BRUCELLA VACCINE; BRUCELLOSIS; COMPLEMENT SYSTEM PROTEINS; ELECTROPORATION; FREUND'S ADJUVANT; IMMUNITY, HUMORAL; IMMUNOGLOBULIN G; INTERFERON-GAMMA; LIPIDS; MALE; MULTIENZYME COMPLEXES; PLASMIDS; RECOMBINANT PROTEINS; SAPONINS; SHEEP; SHEEP DISEASES;

EID: 70350749415     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2009.08.097     Document Type: Article

References (38)

1. Blasco J.M. Brucella ovis. In: Nielsen K., and Duncan J.R. (Eds). Animal brucellosis (1990), CRC Press, Inc, Boca Ratón, FL 352-378
2. Manual for diagnostic tests and vaccines for terrestrial animals. Caprine and ovine brucellosis (excluding Brucella ovis) (2004), O.I.E. chapter 2.4.2
3. Blasco J.M., Marín C.M., Barberán M., Moriyón I., and Díaz R. Immunization with Brucella melitensis Rev. 1 against B. ovis infection of rams. Vet Microbiol 14 4 (1987) 381-392
4. Marín C.M., Barberán M., Jimenez de Bagués M.P., and Blasco J.M. Comparison of subcutaneous and conjunctival routes of Rev 1 vaccination for the prophylaxis of Brucella ovis infection in rams. Res Vet Sci 48 2 (1990) 209-215
5. Crespo León F. Brucelosis ovina y caprina. Vacunas y vacunación (1994), O.I.E. Capítulo X
6. Blasco J.M., Gamazo C., Winter A.J., Jiménez de Bagués M.P., Marín C., Barberán M., et al. Evaluation of whole cell and subcellular vaccines against Brucella ovis in rams. Vet Immunol Immunopathol 37 3-4 (1993) 257-270
7. Muñoz P.M., Estevan M., Marín C.M., De Miguel M.J., Grilló M.J., and Barberán M. Brucella outer membrane complex-loaded microparticles as a vaccine against Brucella ovis in rams. Vaccine 24 11 (2006) 1897-1905
8. Babiuk L.A., Pontarollo R., Babiuk S., Loher B., and Van Drunen Little-van den Hurk S. Induction of immune responses by DNA vaccines in large animals. Vaccine 21 7-8 (2003) 649-658
9. Dhama K., Mahendran M., Gupta P.K., and Rai A. Review article: DNA vaccines and their applications in veterinary practice: current perspectives. Vet Res Commun 32 5 (2008) 341-356
10. Scheerlinck J-PY, Karlis J., Tjelle T.E., Presidente P.J.A., Mathiesen I., and Newton S.E. In vivo electroporation improves immune responses to DNA vaccination in sheep. Vaccine 22 13-14 (2004) 1820-1825
11. Vordermeier M.H., Lowrie D.B., and Hewinson R.G. Improved immunogenicity of DNA vaccination with mycobacterial HSP65 against bovine tuberculosis by protein boosting. Vet Microbiol 93 4 (2003) 349-359
12. Le Gall-Reculé G., Cherbonnel M., Pelotte N., Blanchard P., Morin Y., and Jestin V. Importance of a prime-boost DNA/protein vaccination to protect chickens against low-pathogenic H7 avian influenza infection. Avian Dis 51 s1 (2007) 490-494
13. Dunachie S.J., and Hill A.V.S. Prime-boost strategies for malaria vaccine development. Review article. J Exp Biol 206 10 (2003) 3771-3779
14. Ramshaw I.A., and Ramsay A.J. The prime-boost strategy: exciting prospects for improved vaccination. Immunol Today 21 4 (2000) 163-165
15. Estein S.M., Cassataro J., Vizcaino N., Zygmunt M.S., Cloeckaert A., and Bowden R.A. The recombinant Omp31 from Brucella melitensis alone or associated with rough lipopolysaccharide induces protection against Brucella ovis infection in BALB/c mice. Microbes Infect 5 2 (2003) 85-93
16. Estein S.M., Cheves P.C., Fiorentino M.A., Cassataro J., Paolicchi F.A., and Bowden R.A. Immunogenicity of recombinant Omp31 from Brucella melitensis in rams and serum bactericidal activity against B. ovis. Vet Microbiol 102 3-4 (2004) 203-213
17. Cassataro J., Velikovsky C.A., de la Barrera S., Estein S.M., Bruno L., Bowden R., et al. A DNA vaccine coding for the Brucella outer membrane protein 31 confers protection against B. melitensis and B. ovis infection by eliciting a specific cytotoxic response. Infect Immun 73 10 (2005) 6537-6546
18. Cassataro J., Velikovsky C.A., Bruno L., Estein S.M., De la Barrera S., Bowden R., et al. Improved immunogenicity of a vaccination regimen combining a DNA vaccine encoding Brucella melitensis outer membrane protein 31 (Omp31) and recombinant Omp31 boosting. Clin Vaccine Immunol 14 7 (2007) 869-874
19. Velikovsky C.A., Goldbaum F.A., Cassataro J., Estein S.M., Bowden R.A., Bruno L., et al. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used. Infect Immun 71 10 (2003) 5750-5755
20. Velikovsky C.A., Cassataro J., Giambartolomei G.H., Goldbaum F.A., Estein S., Bowden R.A., et al. A DNA vaccine encoding lumazine synthase from Brucella abortus induces protective immunity in BALB/c mice. Infect Immun 70 5 (2002) 2507-2511
21. Laplagne D.A., Zylberman V., Ainciart N., Steward M.W., Sciutto E., Fossati C.A., et al. Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides. Proteins 57 4 (2004) 820-828
22. Zylberman V., Craig P.O., Klinke S., Braden B.C., Cauerhff A., and Goldbaum F.A. High order quaternary arrangement confers increased structural stability to Brucella sp. lumazine synthase. J Biol Chem 279 9 (2004) 8093-8101
23. Rosas G., Fragoso G., Ainciart N., Esquivel-Guadarrama F., Santana A., Bobes R.J., et al. Brucella spp. lumazine synthase: a novel adjuvant and antigen delivery system to effectively induce oral immunity. Microbes Infect 8 5 (2006) 1277-1286
24. Cassataro J., Pasquevich K.A., Estein S.M., Laplagne D.A., Zwerdling A., De la Barrera S., et al. DNA vaccine coding for the chimera BLSOmp31 induced a better degree of protection against B. ovis and a similar degree of protection against B. melitensis than Rev.1 vaccination. Vaccine 25 22 (2007) 4437-4446
25. Alton G.G., Jones L.M., Angus R.D., and Verger J.M. Techniques for the brucellosis laboratory (1988), INRA, Paris
26. Tjelle T.E., Salte R., Mathiesen I., and Kjeken R. A novel electroporation device for gene delivery in large animals and humans. Vaccine 24 21 (2006) 4667-4670
27. Vigliocco A.M., Silva Paulo P.S., Mestre J., Briones G.C., Draghi G., Tossi M., et al. Development and validation of an indirect enzyme immunoassay for detection of ovine antibody to Brucella ovis. Vet Microbiol 54 3-4 (1997) 357-368
28. Paolicchi F., Terzolo H., Malena R., and Morsella C. Estudio comparativo de medios de cultivo para aislar Brucella ovis. Rev Arg Microbiol 23 3 (1991) 155-159
29. Cassataro J., Estein S.M., Pasquevich K.A., Velikovsky C.A., De la Barrera S., Bowden R., et al. Vaccination with the recombinant Brucella outer membrane protein 31 or a derived 27-amino-acid synthetic peptide elicits a CD4-T helper 1 response that protects against Brucella melitensis infection. Infect Immun 73 12 (2005) 8079-8088
30. Vizcaino N., Kittelberger R., Cloeckaert A., Marin C.M., and Fernandez-Lago L. Minor nucleotide substitutions in the omp31 gene of Brucella ovis result in antigenic differences in the major outer membrane protein that it encodes compared to those of the other Brucella species. Infect Immun 69 11 (2001) 7020-7028
31. Berguer P.M., Mundinano J., Piazzon I., and Goldbaum F.A. A polymeric bacterial protein activates dendritic cells via TLR4. J Immunol 176 4 (2006) 2366-2372
32. Marciani D.J., Pathak A.K., Reynolds R.C., Seitz L., and May R.D. Altered immunomodulating and toxicological properties of degraded Quillaja saponaria Molina saponins. Int Immunopharmacol 1 4 (2001) 813-818
33. Tollefsen S., Tjelle T., Schneider J., Harboe M., Wiker H., Hewinson G., et al. Improved cellular and humoral immune responses against Mycobacterium tuberculosis antigens after intramuscular DNA immunisation combined with muscle electroporation. Vaccine 20 27-28 (2002) 3370-3378
34. Babiuk S., Baca Estrada M.E., Foldvari M., Storms M., Rabussay D., Widera G., et al. Electroporation improves the efficacy of DNA vaccines in large animals. Vaccine 20 27-28 (2002) 3399-3408
35. Luckay A., Sidhu M.K., Kjeken R., Megati S., Chong S.Y., Roopchand V., et al. Effect of plasmid DNA vaccine design and in vivo electroporation on the resulting vaccine-specific immune responses in rhesus macaques. J Virol 81 10 (2007) 5257-5269
36. Rice J., Ottensmeier Ch, and Stevenson F.K. DNA vaccines: precision tools for activating effective immunity against cancer. Nat Rev Cancer 8 (2008) 108-120
37. Matzinger P. Tolerance, danger, and the extended family. Ann Rev Immunol 12 (1994) 991-1045
38. Woodland D.L. Jump-starting the immune system: prime-boosting comes of age. Trends Immunol 25 2 (2004) 98-104